[Safety in the selection of oral antibiotic treatment in community infections, beyond COVID-19]. [PDF]
Barberán J +2 more
europepmc +1 more source
[Suspected serotonergic syndrome associated with tedizolid: a case report]. [PDF]
González-Gómez Á +5 more
europepmc +1 more source
[Relevance of genetic polymorphisms in voriconazole neurotoxicity: case report in a pediatric patient]. [PDF]
Martín-Roldán A +3 more
europepmc +1 more source
[Depression in patients with epilepsy. Pathophysiological and clinical concepts and therapeutic strategies]. [PDF]
Paredes-Aragón E +2 more
europepmc +1 more source
[Selection of pharmacogenomic variants and methodology for their use in community pharmacy]. [PDF]
Montero-Gómez A, Sánchez Pozo A.
europepmc +1 more source
[Study of anticholinergic burden in chronic treatments of outpatients in the Community Pharmacy]. [PDF]
Zaragoza Noguera R +2 more
europepmc +1 more source
[Strategy to optimize patient safety in the community pharmacy dispensing service. Proposed checklists]. [PDF]
Adsuar-Meseguer GM +9 more
europepmc +1 more source
[Role of the Pharmacotherapeutic Monitoring Service (PMS) of the Community Pharmacy in the detection and resolution of adverse reactions to statins linked to possible diagnostic errors in elderly patients]. [PDF]
García Martín DL.
europepmc +1 more source
[Advances and guidance in the treatment of drug-resistant epilepsy: a review by the Andalusian Epilepsy Society of the new drugs cenobamate, fenfluramine and cannabidiol]. [PDF]
Arenas-Cabrera C +7 more
europepmc +1 more source

